8Stock.Com Real Time Signal Analysis By Industry Sectors

8Stock.Com Real Time Signal Analysis
By Industry Sectors.

RSS Stock Market Analysis With Sector Related News Feed

INDUSTRY SECTOR Real Time Intraday Signal

US (Nasdaq, NYSE, AMEX) RSS News Feed

Live Link | INSURANCE | RSS News Feed | LTrader

HEALTH CARE, BIOTECHNOLOGY, DRUGS, PHARMACEUTICALS, MEDICAL

Live Link | HEALTH CARE | RSS News Feed | LTrader

SmarTrend Watching for Pullback in Shares of Enzon Pharmaceuticals After 1.63 ...
Comtex Smartrend
Enzon Pharmaceuticals (NASDAQ:ENZN) traded in a range yesterday that spanned from a low of $10.44 to a high of $10.60. ...

and more »

Shares of Cepheid Rank the Highest in terms of Relative Performance in the ...
Comtex Smartrend
Cepheid (NASDAQ:CPHD) ranks first with a gain of 9.51%; Regeneron Pharmaceuticals (NASDAQ:REGN) ranks second with a gain of 7.3%; and Dendreon (NASDAQ:DNDN) ...

and more »

XOMA Regains NASDAQ Compliance
MarketWatch (press release)
As a result, 60 pharmaceutical and biotechnology companies have signed BCE licenses, and several licensed product candidates are in clinical development. ...
XOMA Regains NASDAQ ComplianceTheStreet.com

all 39 news articles »

Cardiome Achieves $30 Million Milestone
MarketWatch (press release)
Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it has earned a US$30 million milestone payment from its collaboration with Merck ...
Cardiome Pharma shares up on EU approval. Inhibitex reports positive Phase1a ...BioMedReports (subscription) (blog)
BRINAVESS™ (vernakalant) for Infusion Approved in the European Union for ...Financial Post

all 71 news articles »

Best Cash Flow in the Biotechnology Industry Detected in Shares of Neurocrine ...
Comtex Smartrend
Rigel Pharmaceuticals (NASDAQ:RIGL) has a price to free cash flow ratio of 5.6x based on a current price of $8.27 and a free cash flow per share of $1.49. ...

and more »

Highest Level of Efficiency in the Biotechnology Industry Detected in Shares ...
Comtex Smartrend
... third with an RPE of $2.04M. Amylin Pharmaceuticals (NASDAQ:AMLN) follows with an RPE of $1.99M and NPS Pharmaceuticals (NASDAQ:NPSP) rounds out the top ...

and more »

Genzyme CEO Seeks Higher Offer
Wall Street Journal
Genzyme shares traded up 20 cents at $70.11 in 4 pm trading Tuesday on the Nasdaq Stock Market, giving the Cambridge, Mass. biotechnology company a market ...
Genzyme leads drug stocks higherMarketWatch
Sanofi-Aventis (NYSE:SNY) makes Bid for Genzyme (NASDAQ:GENZ)Business and Finance News (blog)
Shocker: Sanofi's Interested in GenzymeMotley Fool
TopNews New Zealand -International Business Times -Trading Markets (press release)
all 1,238 news articles »

Relatively Good Performance Detected in Shares of Halozyme Therapeutics in the ...
Comtex Smartrend
Halozyme Therapeutics (NASDAQ:HALO) ranks first with a gain of 6.26%; Idenix Pharmaceuticals (NASDAQ:IDIX) ranks second with a gain of 5.26%; ...

and more »

Regeneron Pharmaceuticals has the Highest Gross Margin in the Biotechnology ...
Comtex Smartrend
Regeneron Pharmaceuticals (NASDAQ:REGN) has gross margin of 99.7%, a sales growth of 28.7%, and trailing 12 months sales of $433.7 million. ...

and more »

Google News

TECHNOLOGY